UNITED STATES SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
| (Mark one) |
| [X] | Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| For the quarterly period ended March 31, 2003 |
or
| [ ] | Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| For the transition period from to |
| Commission file number: | 0-20784 |
TRIDENT MICROSYSTEMS, INC.
| DELAWARE | 77-0156584 | |
|
|
||
| (State or other jurisdiction of | (I.R.S. Employer Identification No.) | |
| incorporation or organization) |
1090 E. Arques Avenue, Sunnyvale, California 94085
(408) 991-8800
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
The number of shares of the registrants $0.001 par value Common Stock outstanding at March 31, 2003 was 13,696,166.
TRIDENT MICROSYSTEMS, INC.
INDEX
| Page | ||||
| Part I: Financial Information | ||||
| Item 1: | Unaudited Financial Information | |||
| Condensed Consolidated Balance Sheet - March 31, 2003 and June 30, 2002 | 3 | |||
| Condensed Consolidated Statement of Operations for the three months and nine months ended March 31, 2003 and 2002 | 4 | |||
| Condensed Consolidated Statement of Cash Flows for the nine months ended March 31, 2003 and 2002 | 5 | |||
| Notes to the Condensed Consolidated Financial Statements | 6 | |||
| Item 2: | Managements Discussion and Analysis of Financial Condition and Results of Operations | 17 | ||
| Item 3: | Quantitative and Qualitative Disclosures About Market Risk | 32 | ||
| Item 4: | Controls and Procedures | 33 | ||
| Part II: Other Information | ||||
| Item 1: | Legal Proceedings | 34 | ||
| Item 2: | Changes in Securities and Use of Proceeds | 35 | ||
| Item 3: | Defaults upon Senior Securities | 35 | ||
| Item 4: | Submission of Matters to a Vote of Security Holders | 35 | ||
| Item 5: | Other Information | 35 | ||
| Item 6: | Exhibits and Reports on Form 8-K | 36 | ||
| Signatures | 37 | |||
| Certifications | 38 | |||
CONDENSED CONSOLIDATED BALANCE SHEET
(in thousands, unaudited)
| March 31, | June 30, | |||||||||
| 2003 | 2002 | |||||||||
ASSETS |
||||||||||
Current assets: |
||||||||||
Cash and cash equivalents |
$ | 8,801 | $ | 21,193 | ||||||
Short-term
investment - UMC |
37,423 | 61,672 | ||||||||
Short-term
investments - other |
931 | 1,153 | ||||||||
Accounts receivable, net |
1,817 | 4,284 | ||||||||
Inventories |
4,753 | 3,190 | ||||||||
Deferred income taxes |
| 1,247 | ||||||||
Prepaid expenses and other current assets |
1,619 | 1,953 | ||||||||
Total current assets |
55,344 | 94,692 | ||||||||
Property and equipment, net |
3,015 | 4,710 | ||||||||
Long-term
investment - UMC |
4,375 | 10,063 | ||||||||
Long-term
investments - other |
3,944 | 8,642 | ||||||||
Other assets |
344 | 417 | ||||||||
Total assets |
$ | 67,022 | $ | 118,524 | ||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||||
Current liabilities: |
||||||||||
Accounts payable |
$ | 6,366 | $ | 6,709 | ||||||
Accrued expenses |
9,944 | 10,201 | ||||||||
Income taxes payable |
1,385 | 3,980 | ||||||||
Total current liabilities |
17,695 | 20,890 | ||||||||
Deferred income taxes non-current |
| 6,338 | ||||||||
Minority interest in subsidiary |
| 640 | ||||||||
Total liabilities |
17,695 | 27,868 | ||||||||
Stockholders equity: |
||||||||||
Common stock and additional paid-in capital |
56,591 | 56,319 | ||||||||
Treasury stock, at cost |
(17,952 | ) | (17,952 | ) | ||||||
Retained earnings |
19,170 | 39,345 | ||||||||
Accumulated other comprehensive gain (loss) |
(8,482 | ) | 12,944 | |||||||
Total stockholders equity |
49,327 | 90,656 | ||||||||
Total liabilities and stockholders equity |
$ | 67,022 | $ | 118,524 | ||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
- 3 -
TRIDENT MICROSYSTEMS, INC.
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2003 | 2002 | 2003 | 2002 | |||||||||||||
Net sales |
$ | 11,614 | $ | 28,839 | $ | 38,132 | $ | 84,757 | ||||||||
Cost of sales |
7,431 | 22,600 | 25,990 | 66,925 | ||||||||||||
Gross profit |
4,183 | 6,239 | 12,142 | 17,832 | ||||||||||||
Research and development expenses |
5,461 | 5,190 | 17,034 | 16,482 | ||||||||||||
Sales, general and administrative expenses |
2,986 | 3,671 | 9,100 | 10,619 | ||||||||||||
Loss from operations |
(4,264 | ) | (2,622 | ) | (13,992 | ) | (9,269 | ) | ||||||||
Loss on investments, net |
(2,821 | ) | | (4,787 | ) | (41,915 | ) | |||||||||
Interest and other income (expense), net |
(458 | ) | 106 | (350 | ) | 294 | ||||||||||
Loss before income taxes |
(7,543 | ) | (2,516 | ) | (19,129 | ) | (50,890 | ) | ||||||||
(Benefit) provision for income taxes |
| (440 | ) | 1,046 | (17,271 | ) | ||||||||||
Net loss |
$ | (7,543 | ) | $ | (2,076 | ) | $ | (20,175 | ) | $ | (33,619 | ) | ||||
Basic and diluted net loss per share |
$ | (0.55 | ) | $ | (0.15 | ) | $ | (1.48 | ) | $ | (2.51 | ) | ||||
Common shares used in computing basic
and diluted net loss per share |
13,696 | 13,431 | 13,651 | 13,369 | ||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
- 4 -
TRIDENT MICROSYSTEMS, INC.
| Nine Months Ended | ||||||||||||
| March 31, | ||||||||||||
| 2003 | 2002 | |||||||||||
Cash flows from operating activities: |
||||||||||||
Net loss |
$ | (20,175 | ) | $ | (33,619 | ) | ||||||
Adjustments to reconcile net loss to cash used in
operating activities: |
||||||||||||
Depreciation and amortization |
995 | 1,193 | ||||||||||
Provision for doubtful accounts and sales returns |
(1,055 | ) | | |||||||||
Loss on investments |
4,787 | 41,915 | ||||||||||
Deferred income taxes |
3,642 | (16,352 | ) | |||||||||
Changes in assets and liabilities: |
||||||||||||
Accounts receivable, net |
3,522 | 1,271 | ||||||||||
Inventories |
(1,563 | ) | 6,397 | |||||||||
Prepaid expenses and other current assets |
334 | (296 | ) | |||||||||
Other assets |
73 | 238 | ||||||||||
Accounts payable |
(343 | ) | (1,394 | ) | ||||||||
Accrued expenses |
183 | (1,548 | ) | |||||||||
Income taxes payable |
(2,595 | ) | (918 | ) | ||||||||
Net cash used in operating activities |
(12,195 | ) | (3,113 | ) | ||||||||
Cash flows from investing activities: |
||||||||||||
Purchase of investments |
(111 | ) | (50 | ) | ||||||||
Purchase of property and equipment |
(358 | ) | (1,507 | ) | ||||||||
Net cash used in investing activities |
(469 | ) | (1,557 | ) | ||||||||
Cash flows from financing activities: |
||||||||||||
Issuance of common stock |
272 | 850 | ||||||||||
Net cash provided by financing activities |
272 | 850 | ||||||||||
Net decrease in cash and cash equivalents |
(12,392 | ) | (3,820 | ) | ||||||||
Cash and cash equivalents at beginning of period |
21,193 | 26,677 | ||||||||||
Cash and cash equivalents at end of period |
$ | 8,801 | $ | 22,857 | ||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
- 5 -
TRIDENT MICROSYSTEMS, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS
Note 1. The Company
Trident Microsystems, Inc. (the Company) designs, develops and markets integrated circuits for videographics, multimedia and digitally processed television products for the desktop and notebook PC market and consumer television market.
Note 2. Basis of Presentation
The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries after elimination of all significant intercompany accounts and transactions. The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts; actual results could differ from those estimates.
In the opinion of the Company, the unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation of the financial position, operating results and cash flows for those periods presented. The unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and are not audited. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended June 30, 2002 included in the Companys annual report on Form 10-K filed with the Securities and Exchange Commission.
The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for any other period or for the entire fiscal year which ends June 30, 2003.
Note 3. Revenue Recognition
Revenue from product sales is generally recognized upon shipment when persuasive evidence of an arrangement exists, the price is fixed or determinable, shipment is made and collectibility is reasonably assured. Provision is made for expected future sales returns and allowances when revenue is recognized. The Company has no obligation to provide any modification or customization upgrades, enhancements or other post-sale customer support. The Company grants certain distributors limited rights of return and price protection on unsold products. Product revenue on shipments to distributors with such rights is deferred until the Company is notified by the distributors that the products are shipped to end customers by the distributors.
The Companys license revenues are recognized when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and the collectibility is reasonably assured. The Companys license revenue does not require significant production, modification or customization of
The accompanying notes are an integral part of these condensed consolidated financial statements.
- 6 -
software. Royalty revenue is recognized when the Company is informed that the related products have been sold provided that collectibility is reasonably assured.
Note 4. Recent Accounting Pronouncements
In July 2002, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No.146, Accounting for Costs Associated with Exit or Disposal Activities. SFAS No. 146 addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies Emerging Issues Task Force (EITF) Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. The principal difference between SFAS No. 146 and EITF Issue No. 94-3 relates to SFAS No.146s timing for recognition of a liability for a cost associated with an exit or disposal activity. SFAS No. 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred. Under EITF Issue No. 94-3 a liability for an exit cost as generally defined in EITF Issue No. 94-3 was recognized at the date of an entitys commitment to an exit plan. SFAS No. 146 is effective for exit or disposal activities that are initiated after December 31, 2002. SFAS No. 146 is applied prospectively upon adoption and, as a result, would not have any impact on the Companys current financial position or results of operations.
In November 2002, the FASB issued Interpretation No. 45 (FIN 45), Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others. FIN 45 requires that upon issuance of a guarantee, the guarantor must recognize a liability for the fair value of the obligation it assumes under that guarantee and further requires a guarantor to provide additional disclosures regarding guarantees. The Interpretations provisions for initial recognition and measurement should be applied on a prospective basis to guarantees issued or modified after December 31, 2002. The disclosure requirements are effective for financial statements of periods that end after December 15, 2002. The adoption of this Interpretation did not have any effect on the Companys consolidated financial statements.
In December 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based Compensation, Transition and Disclosure. SFAS No. 148 amends SFAS No. 123 and requires prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and effect of the method used on reported results. SFAS No. 148 is effective for fiscal years ended after December 15, 2002 and is effective for interim periods, beginning after December 15, 2002, the adoption of this statement did not have a material effect on the Companys financial position or results of operations.
In January 2003, the FASB issued Interpretation No. 46 (FIN 46), Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51. FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective immediately for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of FIN 46 must be applied for the first interim or annual period beginning after June 15, 2003. The Company believes that the adoption of this Interpretation will have no material impact on its consolidated financial statements.
- 7 -
Note 5. Inventories
Inventories consisted of the following (in thousands):
| March 31, 2003 | June 30, 2002 | |||||||
Work in process |
$ | 1,947 | $ | 585 | ||||
Finished goods |
2,806 | 2,605 | ||||||
| $ | 4,753 | $ | 3,190 | |||||
Note 6. Net Loss Per Share
Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net income per share is calculated using the weighted average number of outstanding shares of common stock plus potential common stock shares. The calculation of diluted net loss per share excludes potential common stock if the effect is antidilutive. Potential common stock shares consist of common stock options, computed using the treasury stock method based on the average stock price for the period.
Reconciliations of the numerators and denominators of the basic and diluted net loss per share calculations are as follows:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| (in thousands, except per share data) | 2003 | 2002 | 2003 | 2002 | ||||||||||||
Basic and Diluted Net Loss per Share |
||||||||||||||||
Net loss |
$ | (7,543 | ) | $ | (2,076 | ) | $ | (20,175 | ) | $ | (33,619 | ) | ||||
Weighted average common shares |
13,696 | 13,431 | 13,651 | 13,369 | ||||||||||||
Basic and diluted net loss per share |
$ | (0.55 | ) | $ | (0.15 | ) | $ | (1.48 | ) | $ | (2.51 | ) | ||||
Common stock equivalents not
included in the calculation because
they are antidilutive |
58 | 1,162 | 88 | 900 | ||||||||||||
Note 7. Stock-based compensation
In accordance with SFAS No. 148, the Company is required to disclose the effects on reported net loss and the basic and diluted net loss per share as if the fair value based method had been applied to all awards. The weighted average estimated grant date fair value, as defined by SFAS No. 123, for stock options granted under its stock option plans during the nine months ended March 31, 2003 and 2002 was $3.49 and $2.14 per share, respectively. The weighted average estimated grant date fair value of stock purchase rights granted pursuant to its employee stock purchase plan during the nine months ended March 31, 2003 and 2002 was $0.62 and $1.35, respectively. The estimated grant date fair value disclosed by the Company is calculated using the Black-Scholes option pricing model. The Black-Scholes model, as well as other currently accepted option valuation models, was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which significantly differ from its stock option and purchase awards. These models also require highly
- 8 -
subjective assumptions, including future stock price volatility and expected time until exercise, which greatly affect the calculated grant date fair value.
The following weighted average assumptions are included in the estimated grant date fair value calculations for its stock option and purchase awards:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2003 | 2002 | 2003 | 2002 | |||||||||||||
Risk-free interest rate |
2.92 | % | 4.97 | % | 2.50 | % | 4.18 | % | ||||||||
Average expected life of option (in years) |
0.5 - 5 | 0.5 - 5 | 0.5 - 5 | 0.5 - 5 | ||||||||||||
Dividend yield |
0 | % | 0 | % | 0 | % | 0 | % | ||||||||
Volatility |
50 | % | 54 | % | 50% - 85 | % | 90 | % | ||||||||
Had the Company recorded compensation based on the estimated grant date fair value, as defined by SFAS No. 123, for awards granted under its stock option plans and stock purchase plan, the net loss and net loss per share would have been changed to the pro forma amounts below for the three and nine months ended March 31, 2003 and 2002:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| (in thousands, except per share data) | 2003 | 2002 | 2003 | 2002 | ||||||||||||
Net loss as reported |
$ | (7,543 | ) | $ | (2,076 | ) | $ | (20,175 | ) | $ | (33,619 | ) | ||||
Less: Stock-based compensation
expense determined under fair
value based method |
(448 | ) | (552 | ) | (1,555 | ) | (1,727 | ) | ||||||||
Pro forma net loss |
$ | (7,991 | ) | $ | (2,628 | ) | $ | (21,730 | ) | $ | (35,346 | ) | ||||
As reported: |
||||||||||||||||
Basic and diluted net loss per share |
$ | (0.55 | ) | $ | (0.15 | ) | $ | (1.48 | ) | $ | (2.51 | ) | ||||
Pro forma: |
||||||||||||||||
Basic and diluted net loss per share |
$ | (0.58 | ) | $ | (0.20 | ) | $ | (1.59 | ) | $ | (2.64 | ) | ||||
Note 8. Investment in UMC
In August 1995, the Company made an investment of $49.3 million in United Integrated Circuits Corpor